Harpoon Therapeutics, Inc. – Trademark Portfolio
Entity Type: 03
Harpoon Therapeutics, Inc. holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 8 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 3 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include TRITAC and HARPOON. The owner is based in South San Francisco, CA.
4000 Shoreline Court, Suite 250
South San Francisco, CA 94080
Showing of trademarks Trademarks
Trademark Classifications
Harpoon Therapeutics, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Harpoon Therapeutics, Inc. have?
Harpoon Therapeutics, Inc. has 9 U.S. trademarks filed with the USPTO. Of these, 3 registered, 5 abandoned, 1 cancelled.
What trademark classes does Harpoon Therapeutics, Inc. file in?
Harpoon Therapeutics, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 5 (Pharmaceuticals), Class 44 (Medical Services). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Harpoon Therapeutics, Inc.'s most well-known trademarks?
Harpoon Therapeutics, Inc.'s registered trademark portfolio includes well-known marks such as TRITAC and HARPOON. These are among 3 currently registered trademarks in the portfolio.
What is Harpoon Therapeutics, Inc.'s trademark registration success rate?
Harpoon Therapeutics, Inc. has a 33% trademark registration rate, with 3 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.